Saturday, November 12, 2022

< + > Reimagining Alzheimer’s (Part 5): Setback For Potential Alzheimer’s Treatment

In the last installment of this series, I discussed a promising treatment for Alzheimer’s disease called lecanemab. Here, I describe a recent setback for lecanemab’s clinical trials and introduce other potential treatments for Alzheimer’s that are currently underway.

No comments:

Post a Comment

< + > Leading Hospital at Home Programs

In February, Congress extended the Acute Hospital Care at Home program through the end of 2030. The program provides waivers to hospitals t...